FOXP3 and neoplasm: Upon statistical analysis, on comparing the CD8 and FoxP3 counts in the tumor vs. non-tumor regions in the cohort, we observed a lower CD8 count (p = 0.034) and a higher FoxP3 count (p=<0.0001) in the tumor region (Figures 2A,B).